{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:36:35Z","timestamp":1761647795960},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Magnetic Resonance Imaging"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.mri.2010.03.043","type":"journal-article","created":{"date-parts":[[2010,10,28]],"date-time":"2010-10-28T08:17:04Z","timestamp":1288253824000},"page":"32-39","source":"Crossref","is-referenced-by-count":15,"title":["Assessment of metabolic changes in the striatum of a MPTP-intoxicated canine model: in vivo 1H-MRS study of an animal model for Parkinson's disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Chi-Bong","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geon-Ho","family":"Jahng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwi-Yool","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Young","family":"Choe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Nam","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dal-Mo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Vin","family":"Yim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo-Suk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mri.2010.03.043_bb0005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.mri.2010.03.043_bb0010","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0140-6736(05)60746-5","article-title":"Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. The European consortium on genetic susceptibility in Parkinson's disease and the French Parkinson's disease genetics study group","volume":"352","author":"Lucking","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.mri.2010.03.043_bb0015","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in alpha-synuclein gene in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.mri.2010.03.043_bb0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-510X(91)90311-T","article-title":"Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease","volume":"104","author":"Bindoff","year":"1991","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.mri.2010.03.043_bb0025","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.410260606","article-title":"Abnormalities of the electron transport chain in idiopathic Parkinson's disease","volume":"26","author":"Parker","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mri.2010.03.043_bb0030","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"1990. Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.mri.2010.03.043_bb0035","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mri.2010.03.043_bb0040","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","article-title":"Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine","volume":"36","author":"Nicklas","year":"1985","journal-title":"Life Sci"},{"key":"10.1016\/j.mri.2010.03.043_bb0045","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0024-3205(87)90299-2","article-title":"MPTP, MPP+ and mitochondrial function","volume":"40","author":"Nicklas","year":"1987","journal-title":"Life Sci"},{"key":"10.1016\/j.mri.2010.03.043_bb0050","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mri.2010.03.043_bb0055","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1993.tb13610.x","article-title":"Advances in our understanding of the mechanisms of neurotoxicity of MPTP and related compounds","volume":"61","author":"Tipton","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.mri.2010.03.043_bb0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-0404.1987.tb07913.x","article-title":"Positron emission tomography (PET) in the study of dopamine receptors in the primate brain: evaluation of a kinetic model using 11C-N-methyl-spiperone","volume":"75","author":"Eckernas","year":"1987","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.mri.2010.03.043_bb0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nbd.2008.03.012","article-title":"study of dopamine transporters in Parkinson's disease: relevance of age at onset","volume":"31","author":"Panzacchi","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.mri.2010.03.043_bb0070","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/mds.22212","article-title":"Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C] DASB","volume":"23","author":"Boileau","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.mri.2010.03.043_bb0075","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.21315","article-title":"Higher nigrostriatal dopamine neuron loss in early than late onset Parkinson's disease? A [99mTc]-TRODAT-1 SPECT study","volume":"22","author":"Shih","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.mri.2010.03.043_bb0080","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/mds.21505","article-title":"Role of DAT-SPECT in the diagnostic work up of Parkinsonism","volume":"22","author":"Scherfler","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.mri.2010.03.043_bb0085","first-page":"332","article-title":"T2-weighted MRI in Parkinson's disease: substantia nigra pars compacta hypointensity correlates with the clinical scores","volume":"52","author":"Atasoy","year":"2004","journal-title":"Neurol India"},{"key":"10.1016\/j.mri.2010.03.043_bb0090","first-page":"309\u2212313","article-title":"Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging","volume":"28","author":"Minati","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.mri.2010.03.043_bb0095","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1212\/WNL.49.2.438","article-title":"Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study","volume":"49","author":"Ellis","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.mri.2010.03.043_bb0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/jnnp.62.3.239","article-title":"Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy","volume":"62","author":"Federico","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mri.2010.03.043_bb0105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/A:1020609530444","article-title":"A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease","volume":"14","author":"Taylor-Robinson","year":"1999","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.mri.2010.03.043_bb0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s100720170051","article-title":"Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients","volume":"22","author":"Lucetti","year":"2001","journal-title":"Neurol Sci"},{"key":"10.1016\/j.mri.2010.03.043_bb0115","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1468-1331.2000.00111.x","article-title":"Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy","volume":"7","author":"Clarke","year":"2000","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.mri.2010.03.043_bb0120","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/mds.21576","article-title":"Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI\/MRS study","volume":"22","author":"Lucetti","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.mri.2010.03.043_bb0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jnnp.67.1.20","article-title":"Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study","volume":"67","author":"Hu","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mri.2010.03.043_bb0130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neulet.2003.09.076","article-title":"Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia","volume":"354","author":"Camicioli","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mri.2010.03.043_bb0135","first-page":"61","article-title":"spectroscopy of the brain in 14 patients with Parkinson disease","volume":"16","author":"Bowen","year":"1995","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.mri.2010.03.043_bb0140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/nbm.1305","article-title":"Assessment of metabolic changes in the striatum of a rat model of parkinsonism: an in vivo 1H-MRS study","volume":"22","author":"Kickler","year":"2009","journal-title":"NMR Biomed"},{"key":"10.1016\/j.mri.2010.03.043_bb0145","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1471-4159.2007.05185.x","article-title":"Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse","volume":"105","author":"Chassain","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.mri.2010.03.043_bb0150","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1460-9568.2006.04610.x","article-title":"1H-MRS identifies lactate rise in the striatum of MPTP-treated C57BL\/6 mice","volume":"23","author":"Koga","year":"2006","journal-title":"Eur J Neurosci"},{"issue":"7","key":"10.1016\/j.mri.2010.03.043_bb0155","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1523\/JNEUROSCI.4364-04.2005","article-title":"Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease","volume":"25","author":"Boska","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.mri.2010.03.043_bb0160","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/3300","article-title":"Combined PET\/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease","volume":"4","author":"Brownell","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.mri.2010.03.043_bb0165","first-page":"11","article-title":"The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease","volume":"20","author":"Jenner","year":"1986","journal-title":"J Neural Transm"},{"key":"10.1016\/j.mri.2010.03.043_bb0170","series-title":"Veterinary neuroanatomy and clinical neurology","author":"De Lahunta","year":"1983"},{"key":"10.1016\/j.mri.2010.03.043_bb0175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0014-4886(86)90070-1","article-title":"Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology, and biochemistry","volume":"91","author":"Schneider","year":"1986","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.mri.2010.03.043_bb0180","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0306-4522(91)90066-W","article-title":"Neurochemical evaluation of the striatum in symptomatic and recovered MPTP-treated cats","volume":"44","author":"Schneider","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.mri.2010.03.043_bb0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF02668096","article-title":"Java-based graphical user interface for the MRUI quantitation package","volume":"12","author":"Naressi","year":"2001","journal-title":"Magn Reson Mater Phy"},{"key":"10.1016\/j.mri.2010.03.043_bb0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/jmre.1997.1244","article-title":"Improved method for accurate and efficient quantification of MRS data with use of prior knowledge","volume":"129","author":"Vanhamme","year":"1997","journal-title":"J Magn Reson"},{"key":"10.1016\/j.mri.2010.03.043_bb0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1097-4547(19990715)57:2<195::AID-JNR5>3.0.CO;2-P","article-title":"Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease","volume":"57","author":"Duan","year":"1999","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.mri.2010.03.043_bb0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbr.2006.07.004","article-title":"Sexually dimorphic postural adjustments during vertical behaviour are altered in a unilateral 6-OHDA rat model of Parkinson's disease","volume":"174","author":"Field","year":"2006","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.mri.2010.03.043_bb0205","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbadis.2007.12.006","article-title":"Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin model of Parkinson's disease","volume":"1782","author":"Stack","year":"2008","journal-title":"Biochimica Et Biophysica Acta"},{"issue":"6","key":"10.1016\/j.mri.2010.03.043_bb0210","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1468-1331.2001.00308.x","article-title":"Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes","volume":"8","author":"Clarke","year":"2001","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.mri.2010.03.043_bb0215","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/00001756-199605310-00014","article-title":"Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo","volume":"31","author":"Bates","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.mri.2010.03.043_bb0220","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/(SICI)1099-1492(199812)11:8<423::AID-NBM538>3.0.CO;2-V","article-title":"High resolution MRI and MRS: a feasibility study for the investigation of focal cerebral ischemia in mice","volume":"11","author":"Hesselbarth","year":"1998","journal-title":"NMR Biomed"},{"key":"10.1016\/j.mri.2010.03.043_bb0225","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jmri.1213","article-title":"Application of magnetic resonance to animal models of cerebral ischemia","volume":"14","author":"Hoehn","year":"2001","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.mri.2010.03.043_bb0230","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0014-4886(02)00015-8","article-title":"Proton magnetic resonance imaging and spectroscopy identify metabolic changes in the striatum in the MPTP feline model of parkinsonism","volume":"179","author":"Podell","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.mri.2010.03.043_bb0235","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000064927","article-title":"A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease","volume":"14","author":"Firbank","year":"2002","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.mri.2010.03.043_bb0240","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.brainres.2007.10.059","article-title":"Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy","volume":"1189","author":"Van Vlieta","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.mri.2010.03.043_bb0245","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.410370211","article-title":"Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy","volume":"37","author":"Davie","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mri.2010.03.043_bb0250","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0730-725X(97)00079-9","article-title":"spectroscopic imaging of the striatum in Parkinson's disease","volume":"15","author":"Cruz","year":"1997","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.mri.2010.03.043_bb0255","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","article-title":"Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP","volume":"318","author":"Schober","year":"2004","journal-title":"Cell Tissue Res"},{"issue":"7","key":"10.1016\/j.mri.2010.03.043_bb0260","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","article-title":"Interactions between glutamatergic and monoaminergic systems within the basal ganglia: implications for schizophrenia and Parkinson's disease","volume":"13","author":"Carlsson","year":"1990","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.mri.2010.03.043_bb0265","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.expneurol.2004.09.017","article-title":"Cerebral glutamate metabolism in Parkinson's disease: an in vivo dynamic 13C NMS study in the rat","volume":"191","author":"Chassain","year":"2005","journal-title":"Exp Neurol"}],"container-title":["Magnetic Resonance Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X10001517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X10001517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T06:22:25Z","timestamp":1544163745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0730725X10001517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0730725X10001517"],"URL":"https:\/\/doi.org\/10.1016\/j.mri.2010.03.043","relation":{},"ISSN":["0730-725X"],"issn-type":[{"value":"0730-725X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}